Literature DB >> 19745794

Evaluation of male infertility.

P N Schlegel1.   

Abstract

Infertility is an emotionally charged problem affecting an estimated 15% of all couples. The man should be evaluated concurrently with the woman, since a male factor is the primary or contributing cause in 40% to 60% of cases. In addition to detecting treatable abnormalities, evaluation of the infertile man is critical to uncover life-threatening problems associated with the symptom of infertility, as well as genetic conditions associated with male infertility that could be transmitted to offspring with assisted reproduction. New diagnostic tests have been developed and surgical techniques refined resulting in improved treatment results and patient care. Dramatic advancements in, and widespread use of, assisted reproductive techniques such as intracytoplasmic sperm injection have created alternatives for couples who previously had little hope of reproductive success. The infertility practitioner should have a thorough understanding of the advantages and limitations of various laboratory tests as well as the indications, costs and success rates of all treatment options. The first step in evaluation is a thorough history and physical examination with initiation of basic laboratory studies.

Entities:  

Mesh:

Year:  2009        PMID: 19745794

Source DB:  PubMed          Journal:  Minerva Ginecol        ISSN: 0026-4784


  31 in total

1.  Can DNA fragmentation of neat or swim-up spermatozoa be used to predict pregnancy following ICSI of fertile oocyte donors?

Authors:  Jaime Gosálvez; Pedro Caballero; Carmen López-Fernández; Leonor Ortega; José Andrés Guijarro; José Luís Fernández; Stephen D Johnston; Rocío Nuñez-Calonge
Journal:  Asian J Androl       Date:  2013-10-14       Impact factor: 3.285

2.  Expansion and long-term culture of human spermatogonial stem cells via the activation of SMAD3 and AKT pathways.

Authors:  Ying Guo; Linhong Liu; Min Sun; Yanan Hai; Zheng Li; Zuping He
Journal:  Exp Biol Med (Maywood)       Date:  2015-06-18

Review 3.  Adult somatic cells to the rescue: nuclear reprogramming and the dispensability of gonadal germ cells.

Authors:  Charles A Easley; David R Latov; Calvin R Simerly; Gerald Schatten
Journal:  Fertil Steril       Date:  2014-01       Impact factor: 7.329

Review 4.  Microsurgical epididymal sperm aspiration: indications, techniques and outcomes.

Authors:  Aaron M Bernie; Ranjith Ramasamy; Doron S Stember; Peter J Stahl
Journal:  Asian J Androl       Date:  2012-11-19       Impact factor: 3.285

5.  Unraveling epigenomic abnormality in azoospermic human males by WGBS, RNA-Seq, and transcriptome profiling analyses.

Authors:  Xiaolong Wu; Chunhai Luo; Longfei Hu; Xue Chen; Yunmei Chen; Jue Fan; C Yan Cheng; Fei Sun
Journal:  J Assist Reprod Genet       Date:  2020-02-13       Impact factor: 3.412

6.  Associated factors with male infertility: a case control study.

Authors:  Mohammad Reza Hafezi Ahmadi; Masood Yasemi; Hadi Peyman; Karim Hemati; Javaher Khajavikhan; Monireh Yaghoubi; Lida Bimanand
Journal:  J Clin Diagn Res       Date:  2014-09-20

7.  Imaging in male-factor obstructive infertility.

Authors:  Ragab H Donkol
Journal:  World J Radiol       Date:  2010-05-28

Review 8.  Leydig cell aging and hypogonadism.

Authors:  M C Beattie; L Adekola; V Papadopoulos; H Chen; B R Zirkin
Journal:  Exp Gerontol       Date:  2015-02-18       Impact factor: 4.032

9.  Drug ligand-induced activation of translocator protein (TSPO) stimulates steroid production by aged brown Norway rat Leydig cells.

Authors:  J Y Chung; H Chen; A Midzak; A L Burnett; V Papadopoulos; B R Zirkin
Journal:  Endocrinology       Date:  2013-03-22       Impact factor: 4.736

10.  Direct differentiation of human pluripotent stem cells into haploid spermatogenic cells.

Authors:  Charles A Easley; Bart T Phillips; Megan M McGuire; Jennifer M Barringer; Hanna Valli; Brian P Hermann; Calvin R Simerly; Aleksander Rajkovic; Toshio Miki; Kyle E Orwig; Gerald P Schatten
Journal:  Cell Rep       Date:  2012-08-23       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.